<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>The Cdc31p-binding Protein Karlp Is Component Half Bridge of <br /> the Yeast Spindle Pole Body <br /> A n n e Spang, Iain Courtney, Katrin Grein, M o n k Matzner, n d E l m r Schiebel <br /> Max-Planck-Institut fiir Biochemie, Genzentrum, Am Klopferspitz 18a, D-82152 Martinsried, Germany <br />  <br />  <br />  <br />  <br /> <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span>. KARl identified essential                          Fackler, M. Matzner, E. Schiebel. 1993. J. Cell <br /> gene involved karyogamy mating yeast                         Biol. 123:405-416). Using vitro assay dem- <br /> cells spindle pole body duplication mitotic                       onstrate Cdc31p specifically interacts short <br /> ceils (Rose, M. D., G. R. Fink. 1987. Cell.                             sequence carboxy terminal half Karlp. <br /> 48:1047-1060). We investigated cell cycle-                              The potential Cdc31p-binding sequence Karlp con- <br /> dependent localization Karl protein (Karlp)                      tains acidic amino acids in <br /> its interaction SPB components. Karlp                         calmodulin-binding peptides, explaining different <br /> associated spindle pole body entire                     substrate specificities Cdc3 lp calmodulin. <br /> cell cycle yeast. Immunoelectron microscopic                             Cdc31p able bind carboxy terminus <br /> studies anti-Karlp antibodies mono-                        Nufip/Spc110p, component SPB (Kil- <br /> clonal antibody 12CA5 using epitope-tagged, func-                        martin, J. V., S. L. Dyos, D. Kershaw, J. T. <br /> tional Karlp revealed Karlp associated                     Finch. 1993. J. Cell Biol. 123:1175-1184). The associ- <br /> half bridge bridge spindle pole body.                         ation Karlp spindle pole body inde- <br /> Cdc3 lp, Ca2+-binding protein, previously                             pendent Cdc31p. Cdc31p, hand, was <br /> identified component half bridge                     associated SPBs karl cells. <br /> the spindle pole body (Spang, A., I. Courtney, U. <br />  <br />  <br />  <br />        HE direction, number polarity microtubules                 cytoplasmic margin nuclear envelope one <br />  <br /> T      eukaryotic cell organized microtubule or- <br />        ganizing centers (MTOC) ~. The prominent <br /> MTOC centrosome highereukaryotes. The spindle <br />                                                                             SPB (Byers Goetsch, 1975; Byers, 1981a,b). <br />                                                                             The half bridge just specialized section nuclear <br />                                                                             envelope, remains associated enriched SPBs <br /> pole body (SPB) homologue centrosome                   nuclear envelope dissolved detergent (Spang <br /> yeast Saccharomyces cerevisiae. The SPB cylindrical                    et al., 1993). <br /> multilaminated organelle embedded nuclear                      The SPB duplicates just cell cycle Sac- <br /> envelope (Byers Goetsch, 1975). A number substruc-                   charomyces cerevisiae. In early G~, structure called the <br /> tures SPB detectable electron microscopy (see                 satellite forms cytoplasmic face half bridge. Af- <br /> Fig. 9 A). The central plaque contact nuclear                ter START cell cycle SPBs observed side <br /> envelope. Inner outer plaques function nucleation                    nuclear envelope. The duplicated SPBs are <br /> sites nuclear cytoplasmic microtubules, respec-                 connected half bridges, called bridge. <br /> tively (Byers Goetsch, 1975; Byers, 1981a,b). The cen-                  At later stage, bridge severed separated <br /> tral plaque disrupted electron dense central line            SPBs form poles mitotic spindle. <br /> (Spang et al., 1993). An additional substructure SPB,                   Several components SPB identified. Spin- <br /> the intermediate line, located outer cen-                dle SPB components molecular mass 110, 90, and <br /> tral plaque (Rout Kilmartin, 1990). The half bridge ap-                 80 kD identified raising monoclonal antibodies <br /> pears electron microscope darkly stained strip                  enriched fraction SPBs (Rout Kilmartin, <br />                                                                              1990). The gene coding ll0-kD SPB component was <br />                                                                             cloned independently different approaches (Mir- <br /> This paper dedicated Dr. lain Courtney died July 1994. <br />   Address correspondence Elmar Schiebel, Max-Planck-lnstitut fiir <br />                                                                             zayan et al., 1992; Geiser et al., 1993; Kilmartin et al., <br /> Biochemie/G-ertzentrum, Am Klopferspitz 18a, D-82152 Martinsried, Ger-       1993). The ll0-kD SPB component (also called Nufip and <br /> many. Tel.: 89 8578 3810. Fax: 89 8578 3969.                                 Spcll0p) predicted coiled-coil structure regulates <br />                                                                             spacing central inner plaque the <br /> 1. Abbreviations used paper: CDC, cell division cycle; DAPI, 4,6-   SPB (Kilmartin et al., 1993). The COOH terminus of <br /> diamidino-2-phenylindole; EGTA, bis-(anfinoethyl)-glycolether-N,N,zV, N&apos;- <br /> tetraacetic acid; 5-FOA, 5-fluoroorotic acid; MTOC, microtubule organiz-    Nuflp/Spcll0p interacts Ca2+-dependent manner with <br /> ing center; PCR, polymerase chain reaction; SPB, spindle pole body.         calmodulin (CAM), component SPB (Sun et <br />  <br />  <br />  &#194;&#169; The Rockefeller University Press, 0021-9525/95/03/863/15 $2.00 <br />  The Journal Cell Biology, Volume 128, Number 5, March 1995 863-877       863 <br />  al., 1992; Geiser et al., 1993). The 90-kD component as-                  Karlp located SPB entire cell cycle of <br /> sociated outer inner plaque SPB (Rout                    Saccharomyces cerevisiae. In addition, Karlp associated <br /> and Kilmartin, 1990). The 80-kD protein bound nuclear                  isolated SPBs component half bridge or <br /> microtubules, particularly close SPB (Rout                      bridge SPB. Therefore, Karlp Cdc3 lp localize <span id='am-6' about='protege:TO' typeof='owl:Thing'>to</span> <br /> and Kilmartin, 1990). Cdc31p-an essential Ca2+-binding                       substructure SPB. The association Karlp <br /> protein-was identified component SPB sub-                  SPB independent Cdc3 lp. On hand, <br /> structure, half bridge (Baum et al., 1986; Spang et al.,                 Cdc3 lp detected SPB cells lacking Karlp. <br /> 1993). KAR/was originally identified role karyog-                  Both SPB components interact vitro. Analysis se- <br /> amy (Conde Fink, 1976). Subsequent studies revealed                      quence Karlp responsible Cdc3 lp binding <br /> its additional function SPB duplication (Rose Fink,                   suggests Cdc31p CaM different binding re- <br /> 1987). These functions mediated separate do-                      quirements. <br /> mains Karlp. The NH2-terminal section Karlp seems <br /> to function karyogamy, COOH terminus                         Materials Methods <br /> Karlp required SPB duplication (Vallen et al., <br /> 1992a,b). The localization wild-type Karlp                       Yeast Strains, Media, Bacterial and <br /> determined. However, overexpressed Karlp-/3-galac-                    Yeast Transformation <br /> tosidase hybrid proteins localized SPB, been <br /> proposed Karlp component SPB. One hybrid                    Table I summarizes yeast strains used study. The stan- <br />                                                                              &#194;&#162;lard medium growth yeast yeast extract, peptone, dextrose <br /> protein lacking essential COOH terminus localized                    growth medium (YPD). Synthetic minimal (SM) medium synthetic <br /> by immunoelectron microscopy outer plaque                      complete (SC) medium prepared described Guthrie Fink <br /> SPB (Vallen et al., 1992b). In addition, Karlp-/3-galac-                (1991). E. coli strains transformed electroporation (Dower et al., <br /> tosidase hybrid protein associated SPB cell                1988). Yeast ceils transformed using lithium acetate method <br /> cycle-dependent manner. After SPB duplication, hybrid                    (Schiestl Gietz, 1989). <br /> protein associated SPBs, usu- <br /> ally entered bud (Vallen et al., 1992b). Re-                DNA Techniques <br /> cently, suggested localization Karlp-/3-              DNA fragments isolated agarose gels Genclean II kit <br /> galactosidase proteins identical stages               Bio 101 (La Jolla, CA). PCR performed Vent polymerase <br /> the localization wild-type Karlp (Biggins Rose, 1994).                supplied New England Biolabs (Schwalbach, Germany). The nuclcotide <br />                                                                              sequence PCR constructs determined chain-termination <br />    In study investigated subcellular localization             method Sanger et al. (1977). All DNA manipulations per- <br /> wild-type Karlp interaction Cdc31p Karlp.                    formed described Sambrook et al. (1989). <br />  <br /> Table I. Yeast Strains <br /> Strain                                                       Genotype                                                           Source reference <br /> $288C        MATc~ real gal2                                                                                               R. Mortimer (Univ. of <br />                                                                                                                              California, Berkeley) <br /> YPH499       ?dATaura3-52 lys2-801 ade2-101 trp1A63 his3A200 leu2A1                                                        Sikorski Hieter (1989) <br /> YPH501       MATcda ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101                                                    Sikorski Hieter (1989) <br />                trp1A63/trp1A63 his3A2OO/his3A200 leu2A1/leu2 A1 <br /> UFM2         MATcda ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101                                                    This study <br />                trp l A63/trp l A63 his3A2OO/his3A200 leu2A1/leu2A1 Akar I ::HIS3/KAR1 <br /> ESM29        MATcx/aura3-52/ura3-52 lys2-8Ol/lys2-801 ade2-1Ol/ade2-101                                                    This study <br />                trp l A63/trp l A63 his3A2OO/his3A200 leu2A1/leu2A1 Akar l ::HIS3 /KAR1 [pSM30/* <br /> ESM32        MATc~/aura3-52/ura3-52 lys2-801/lys2-801 ade2-101/ade2-101                                                    This study <br />                trp I A63/trp 1A63 his3A2OO/his3A200 leu2A1/leu2A 1 Akarl ::HIS3/KAR1 [pBM 12] t <br /> ESM33        MATa ura3-52 lys2-801 ade2-101 trplA63 his3A200 leu2Al Akarl::HIS3 [pSM30]*                                   This study <br /> ESM34        MATa ura3-52 lys2-801 ade2-101 trplA63 his3A200 leu2A1 Akarl::HIS3 IpSM25]&#194;&#167;                                   This study <br /> ESM36        MATa ura3-52 1ys2-801 ade2-101 trp1A63 his3A200 leu2A1 karl::HIS3 [pBMI21*                                    This study <br /> ESM56        MATa ura3-52 lys2-801 ade2-101 trplA63 his3A200 Acdc31::HIS3 Ieu2-MET3-CDC31-LEU2                             Albermann, K., U. <br />                                                                                                                              Fackler, A. Spang, <br />                                                                                                                              K. Grein, and <br />                                                                                                                              E. Schiebel (manuscript <br />                                                                                                                              preparation) <br /> ESMI15       MATa ura3-52 lys2-801 ade2-101 trplA63 his3A200 leu2A1 Akarl::HIS3 [pSM46/II                                  This study <br /> Y49          MATa cdc15-1 ura3 leu2 ade2 his3 trpl-1                                                                       K. Nasmyth (I.M.P., <br />                                                                                                                              Vienna) <br /> Y255         MATa leu2-3 leu2-112 clnl::HISG cln2 cln3::GAL-CLN3 cdc28-4 [p2151~                                           T. Schuster (Univ. of <br />                                                                                                                              Wiirzburg) <br /> BJ5626       MATa/c~ ura3-52/ura3-52 trpl/TRP1 Ieu2AI/LEU2 his3A2OO/his3A200                                               E. Jones (Carnegie Mellon <br />               pep4::HlS3/pep4:: HIS3 prb I A 1.6R/prb I A 1.6R I/can 1                                                   Univ., Pittsburgh) <br /> MS2083       MATa trp l-A1 leu2-3 1eu2-112 ura3-52 karl-A17                                                                Vallen et al. (1994) <br />  <br /> * pSM30 pRS316 (Sikorski Hieter, 1989) derivative contains restriction fragment KARl. <br /> :~pBM12 pRS316 derivative contains KARl-HA. <br /> &#194;&#167; pSM25 pRS316 derivative containing GST-KAR1. <br /> II pSM46 pRS414 (Sikorski Hieter, 1989) derivative containing KARl control MET3 promoter. <br /> &#194;&#182; p215 LEU2-based plasmid bearing GAL-CLN1. <br />  <br />  <br />  <br /> The Journal Cell Biology, Volume 128, 1995                                 864 <br />  Construction GST-KARI GST-NUF1/SPCIIO                                     cloning site pUCI8. The sense primer (CAM-3) designed that <br /> Gene Fusions, Construction Epitope-Tagged                                  translation initiation codon (ATG) CDM1 formed NdeI re- <br />                                                                                  striction site. The PCR product subeloned NdeI PstI re- <br /> KARl, Construction CDM1 Expression Plasmid                                  striction sites oftbe expression vector pTT-7 (Tabor Richardson, 1985) <br /> GST-KARL The KAR/gene plasmid pMR76 (Rose Fink, 1987)                 generated recombinant plasmid, named pSM71. Plasmid pSM71 <br /> amplified PCR primers KARl-Barn (5&apos;-CCGTGCJGATCCATG-                 expressed CaM control T7 promoter. <br /> TAACTTCTCCAAA-3&apos;) KARl-IV 5&apos;-CGTAATCTGGAACGTCATA- <br /> TG-3&apos;). The PCR product restricted BamHl EcoRl sub-             Strain Constructions <br /> cloned multiple cloning site plasmid pGEX-3X (Pharmacia <br /> Biotech Inc., Piscataway, NJ) resulting gene fusion glutathione-S-       UFM2 (KARI/Akarl::HIS3). KAR/ disrupted one-step gene <br /> transferase (GST) KAR/(GST-KAR/). The plasmid named pSM9.                replacement Rothstein (1983). A 2,630-bp HindlII-EcoRI fragment of <br />     GST-AKAR/: Plasmid pSM9 restricted Baml-IIand HindlI. The           pMR76 (Rose Fink, 1987) carrying KAR/gene cloned the <br /> 1,158-bp fragment isolated cloned BamHl, SmaI restriction       HindlII-EcoRl sites vector pBluescript SK (Stratagene, La Jolla, CA). <br /> sites vector pGEX-3X. The recombinant plasmid generated named             The generated recombinant plasmid named pSMI 1. A 882-bp NsiI frag- <br /> pSM95. GST-AKarlp contained NH2 terminus (amino acids 1 386)              ment located coding region KAR/was substituted HIS3 <br /> of Karlp fused COOH terminus GST.                                      gene 1,157-bp PstI fragment. The resulting plasmid pUF4 re- <br />     GST-AAKAR/:pSM9 restricted BamHI XmnI. The 702-bp               stricted SacI SalI; fragments transformed diploid <br /> fragment cloned pGEX-3X restricted BamHI SmaI. The             yeast strain YPH501 (Sikorski Hieter, 1989), selection on <br /> plasmid generated named pSM57. GST-AAKarlp contains NH2                  SC Media plates lacking histidine. The construction oftbe UFM2 strain was <br /> terminus (amino acids 1 237) Karlp fused COOH terminus              confirmed Southern analysis. Chromosomal DNA His+ transfor- <br /> of GST.                                                                          mants (UFM2) parental strain (YPH501) isolated digested <br />     GST-AKAR/-A:The 456-bp XrnnI-Hindll fragment KAR/was cloned               restriction endonuclease HindlII EcoRI. The fragments DNA <br /> into Smal site vector pGEX-5X (Pharmacia Biotech Inc.). The result-       separated agarose gel transferred Hybond-N membrane <br /> ing plasmid named pSM137. The GST-AKarlp-A fusion protein con-               (Amersham Buehler, Braunschweig, Germany) vacuum blotting. The <br /> tains amino acids 237 386 Karlp fused COOH terminus             BgllI-SaclI fragment pSMll (which carries entire KAR/coding re- <br /> of GST.                                                                          gion) labeled digoxigenin used probe Southern analysis. <br />     GST-AKAR1-2A: Plasmid pSM137 restricted enzymes NsiI            Preparation labeled probe, hybridization, detection performed <br /> and Sail. The Sall restriction site located multiple cloning site   kit Boehringer Mannheim. One fragment 2,630-bp <br /> pGEX-5X NsiI restriction site coding region KARL Blunt         <span id='am-5' about='xsp:length' typeof='owl:Thing'>length</span> detected DNA YPH501 using KAR/probe. With <br /> ends generated T4 DNA polymerase (Boehringer Mannheim,                 UFM2, additional fragments detected 1,560-and 1,150-bp in- <br /> Mannheim, Germany). The vector religated plasmid pSM148.             dicating chromosomal copy KAR/was substituted HIS3 <br /> GST-AKarlp-2Acontains amino acids 237 350 fused COOH termi-            gene (data shown). <br />  nus GST.                                                                        ESM29andESM32. UFM2 transformed plasmids pSM30 (car- <br />     GST-AKARI-3A: Plasmid pSM137 restricted restriction en-         ries 2,630-bp HindlII-EcoRI KAR/-fragment pMR76 pRS316) or <br /> zymes BsmI Sail. BsmI located open reading frame KARL           pBMI2 (KARl-HA pRS316) selection SC Medium plates <br /> The 3&apos; 5&apos; ends converted blunt ends T4 DNA polymerase.          lacking uracil. The transformants named ESM29 ESM32, respeC- <br />  The vector religated plasmid pSM147. GST-AKarlp-3A             tively. <br />  contains amino acids 237 272 fused COOH terminus GST.                ESM33 ESM36. ESM29 ESM32 sporulated, spores <br />     GST-AKARI-4A: Plasmid pSM137 restricted restriction en-         20 tetrads analyzed. Cells derived spores ESM29 and <br />  zyme XhoI. The linearized fragment partially restricted en-        ESM32 His+, Urn&#195;&#183;, indicating KAR/on pSM30 KARl-HA <br />  zyme RcaI. The ends blunted 1&quot;4 polymerase religated.        pBM12 functional. His+, Ura- colonies obtained. <br />  The construction confirmed sequencing. GST-AKarlp-4A contains            Haploid colonies His +, Ura+ sporulation ESM29. <br />  amino acids 237 255 fused COOH terminus GST.                     ESM32 named ESM33 (Akarl::HlS3 [pSM30]) ESM36 <br />     KARl-HA: A NotI restriction site constructed PCR 3&apos; end        (Akarl::HIS3 [pBMI2]), respectively. ESM29 ESM32 unable to <br />  KAR/gene using primers KARl-VIII (5&apos;-GAACTGCGC~CGCTAA-                   grow 5-fluoroorotic acid (5-FOA) plates suggesting plasmids pSM30 <br />  ACCTATAATACACATA-3&apos;)and KARl-IX (5&apos;-GAACTC_~GGCCGCTAAA-                         pBM12 essential viability strains. <br />  CCATATAAAGGTTAG-3&apos;). The ll4-bp Not/fragment ofplasmid GTEP-I                       ESMll5. The KAR/gene amplified PCR primers KAR1-Nde <br />  (was kindly provided Dr. Futcher, Cold Spring Harbor Lab., Cold Spring       (5&apos;-ACGGACATATGAATGTAACTTCTCCAA-3&apos;) KARl-IV (5&apos;-CGT- <br />  Harbor, NY) carrying repeats <span id='am-3' about='Thesaurus:code' typeof='owl:Thing'>code</span> hemagglutinin epi-        AATCTGGAACGTCATATG-3&apos;). Primer KAR1-Nde complementary to <br />  tope (YPYDVPDYA)was inserted NotI restriction site 3&apos; end       5&apos; end KAR/ coding region. The 1,640-bp PCR fragment was <br />  KAR/. KARl-HA cloned pRS316 (Sikorski Hieter, 1989)          treated Sure clone kit Pharmacia (Freiburg, Germany) and <br />  plasmid pBM12.                                                             ligated EcoRV site plasrnid priAM8 (Mountain et al., 1991). Plas- <br />      GS&apos;I:N-NUFI: The 5&apos; end NUF1/SPC110 (Mirzayan et al., 1992)          mid priAM8 carries MET3 promoter pUC19. The recombinant pins- <br />  cloned PCR using primers NUFI-I (5&apos;-CGTGGGATCCACGAAC,&apos;CGTC-                  mid named pSM45. A SalI-EcoRI DNA fragment carrying MET3- <br />  ACATCTC-3&apos;) NUFI-2 (5&apos;-ITrC&apos;IVJAATTCT&apos;VIV~T&apos;VIV_ATGC-33and                  KAR/ gene fusion cloned yeast E. coli shuttle vector <br />  chromosomal DNA yeast strain $288C template. The DNA frag-            pRS414 (Sikorski Hieter, 1989). The resulting plasmid named <br />  ment restricted BamHI EcoRI cloned BamHI-EcoRl             pSM46. Plasmid pSM46 transformed yeast strain ESM33 selection <br />  sites vector pGEX-3X. The plasmid named pSM72. GST-N-Nuflp               SC Medium plates lacking uracil tryptophan. Transfor- <br />  contains amino acids 2 175 Nuflp/Spcll0p fused COOH termi-         mants streaked SM Medium plates supplemented <br />  nus GST.                                                                     adenine, leucine, lysine, uracil, 5-FOA. The MET3 promoter is <br />      GST-C-NUbI: The 3&apos; end NUFI cloned PCR using primers              active growth medium does contain methionine. 5-FOA <br />  NUF1-3 (5&apos;-GCTGGGATCCAGAGGCGTAAAGACAATG-3&apos;)and NUF1-4                           selects cells lost URA3-basedplasmid pSM30 (carries KAR/ <br />  (5&apos;-CGTGGGATCCGAAG&apos;I&apos;IV_.AAAGAACTCC-3&apos;). Chromosomal DNA                        control promoter). 5-FOA resistant colonies Ura- <br />  strain $288C used template. The PCR product restricted        unable grow plates containing methionine indicating es- <br />  Baml-II cloned BmHI site vector pGEX-3X            sential KAR/gene (Rose Fink, 1987) control MET3 pro- <br />  plasmid pSM74. GST-C-NuIIp contains amino acids 793-945 fused            moter. This strain named ESMll5 (Akarl::HIS3 [pSM46]). <br />  COOH terminus GST. This region Nuflp/Spcll0p carries CaM                  ESM34. The GST-KARI gene fusion plasmid pSM9 amplified by <br />  binding site (amino acids 900 927, Geiser et al., 1993).                     PCR using primers KAR1-B (5&apos;-ACTCGCCGCGGTATCCACTTCGATC- <br />     CDM1 amplified PCR primers CAM-1 (5&apos;-CGTGTA-                 ACTTT-3 &apos;) KARl-C (5&apos;-GATACTGCGGCCGCTCCCCTATACTGA-3&apos;). <br />  CTGTGATATGA-3&apos;) CAM-2 (5&apos;-GTTATCCGCCTTGGTAA-3&apos;) using                       KAR1-Bbinds 3&apos; non-coding region KAR/. KARl-C complemen- <br />  chromosomal DNA strain $288C template. The PCR product            tary 5&apos; end GST coding region. The PCR product restricted <br />  cloned pUC18 Sure kit (Pharmacia, Freiburg, Ger-             Notl cloned NotI restriction site plasmid pSM13 give <br />  many). The resulting plasmid named pSM61. The coding region              plasmid pSM25. Plasmid pSMI3 constructed follows. The 5&apos; non- <br />  CDMI amplified PCR primers CAM-3 (5&apos;-CCACGCATA-                coding region KARl amplified primers KARl-I (5&apos;-ACGAAG- <br />  TGTCCTCCAATCTTAC-3&apos;) universe (5&apos;-GTAAAACGACGC~CA-                          GATCCTTTGAATATCAATGAAAAT-3&apos;) KARI-II (5&apos;-GATAC&apos;IV_~G- <br />  GT-3&apos;). Primer universe complementary sequence multiple          GCCGC&apos;~.ATq&apos;V_.A~AAC&apos;IV_AAAAA-3&apos;).The PCR product restricted <br />  <br />  <br />  <br />  <br /> Spang et al. Karlp, Cdc31p-binding Protein SPB Half Bridge              865 <br />  with BamHI Notl cloned BamHI NotI sites             modifications Spang et al. (1993). A 1:500 dilution anti-Karlp <br /> the vector pRS316 (Sikorski Hieter, 1989). Yeast strain UFM2 (KAR//          1:250 dilution 12CA5 antibodies used. The gold particles were <br /> Akarl::HlS3) transformed plasmid pSM25 selection             visualized Jeol JEM 100B electron microscope (Jeol Ltd., Tokyo, <br /> on SC plates lacking uracil. Transformants sporulated tetrads dis-      Japan). <br /> sected. Colonies derived spores UFM2 (ixgM25) Urn+,              Immunofluorescence yeast nuclei yeast cells performed as <br /> His+ (Akarl::HIS3 [pSM25]) obtained high frequency (strain             described Spang et al. (1993) Adams Pringle (1984). Cells were <br /> ESM34).                                                                          fixed 5 min formaldehyde. A 1:1,000 dilution affinity-purified <br />                                                                                  anti-Karlp antibodies used. A pool various mouse monoclonal <br /> Nuclei Isolation, SPB Preparation, Cell                                          anti-90-kD antibodies generous gift Dr. J. Kilmartin. Secondary <br />                                                                                  antibodies goat anti-rabbit IgG conjugated Cy3 goat <br /> Fractionation, Cell Extracts                                                     anti-mouse IgG conjugated FITC Jackson ImmunoResearch <br /> Nuclei SPBs yeast strain BJ5626 ESM36 isolated de-           Laboratories (West Grove, PAl. No signal obtained nuclei cells <br /> scribed Rout Kilmartin (1990). Cells diploid yeast strain          incubated secondary antibodies preimmune <br /> BJ5626 fractionated cell lysate, soluble insoluble frac-    serum. Similarly, signal obtained double-labeling experiments in <br /> tion described Spang et al. (1993). Protein extracts prepared      treatment primary antibodies followed incu- <br /> described Ausubel et ai. (1994).                                              bation &quot;mismatched&quot; secondary antibody. Immunofluorescence mi- <br />                                                                                  croscopy performed Zeiss Axiophot microscope (Carl Zeiss, <br />                                                                                  Oberkochen, Germany). <br /> Isolation GST-Karlp GST-Nuflp <br /> Fusion Proteins                                                                  Immunoblotting, Protein Determination <br /> Expression GST-Karlp E coil BL21 (DE3, pSMg) (Studier                  Protein concentration samples determined using method <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> Moffat, 1986) induced addition 0.5 mM isopropyl-~-D-               Bradford (1976). Proteins separated SDS-PAGE described by <br /> thiogalactopyranoside (IFIG). DE3 E. coil strain BL21 (DE3) indicates         Laemmli (1976). Immunoblotting performed described Spang et <br /> that strain carries lysogenic lambda phage T7 RNA polymer-        al. (1993). Detection enhanced chemiluminescence (ECL) <br /> ase structural gene (Studier Moffat, 1986). The E. coli ceils lysed     using kit Amersham Buchler GmbH 0Braunschweig, Germany). The <br /> after 3 h induction ultrasonication described Spang et al. (1993).   primary antibodies rabbit anti-Cdc31p (Spang et al., 1993), rabbit <br /> The GST-Karlp fusion protein formed inclusion bodies enriched         anti-Karlp, goat anti-Nuflp/Spcll0p (anti-ll0-kD protein), goat anti-E- <br /> by differential centrifugation. Uniysed cells removed low speed cen-     tubulin mouse anti-90-kD antibodies. In case mouse mono- <br /> trifugation (10 rain, 1,000 g, 4&#194;&#176;C). Inclusion bodies collected     clonal anti-90-kD antibody, incubation primary antibody was <br /> centrifugation (15 rain, 10,000 g, 4&#194;&#176;C). The GST-Karlp fusion protein        followed incubation rabbit anti-mouse IgG (Jackson Immuno- <br /> further purified preoperative SDS-PAGE (Laemmli, 1970). The sepa-             Research Laboratories). Secondary antibodies goat anti-rabbit IgG <br /> rated proteins transferred nitrocellulose stained Ponceau     (Bio Pad, Hercules, CA) rabbit anti-goat IgG (Jackson Immuno- <br /> S (Serva Feinbiochemica GmbH &amp; Co. KG, Heidelberg, Germany).                     Research Laboratories) conjugated horseradish peroxidase. <br />     Expression purification GST-AKarlp, GST-AAKarlp, GST- <br /> AKarlp-2A, GST-AKarlp-3A, GST-AKarlp-4A GST-N-Nuflp E. coli <br /> BL21 (DE3), containing corresponding plasmids recommended            Isolation [3sS]Cdc31p [3JS]CaM <br /> by Pharmacia.                                                                    E. coil strain BL21 (DE3, pLysS, pSM5) (Spang et al., 1993) BL21 <br />                                                                                  (DE3, pLysS, pSM71) grown TY medium (bacto trypton, yeast ex- <br /> Preparation Aj~inity-purifiedAnti-Karlp,                                      tract) supplemented 100 #g/rni ampicillin mid-log phase. Plasmid <br /> Anti-N-Nuflp, Anti-~-Tubulin Antibodies                                          pSM5 (Spang et al., 1993) pSM71 contain CDC31 CDMI, respec- <br />                                                                                  tively, control inducible phage T7 promoter (Tabor and <br /> GST-Karlp containing nitrocellulose strips dissolved DMSO          Richardson, 1985). Plasmid pLysS carries T&apos;/lysozyme gene. T7 lyso- <br /> injected rabbits described Harlow Lane (1988). Purified anti-     zyme inhibits residual amounts T7 RNA polymerase induction <br /> Karlp antibodies prepared affinity chromotography described        IPTG (Studier Moffat, 1986). The E. coil cells washed three <br /> Harlow Lane (1988). An E. coli extract containing GST coupled            times M9 minimal medium incubated 1 h 37&#194;&#176;C. IPTG <br /> to CNBr-Sepharose recommended Pharmacia. The IgG fraction con-             (0.5 mM) added cultures induce T7-RNA polymerase. <br /> taining anti-Karlp antibodies run GST E. coli protein           Cells incubated 30 min 37&#194;&#176;C. Finally, rifampicin (200 #g/ml) <br /> column remove anti-GST antibodies. The preabsorbed IgG fraction           added inhibit E. coil RNA polymerase. Cells incubated for <br /> then incubated purified GST-AKarlp coupled CNBr-Sepharose 4B.            30 min 37&#194;&#176;C. Cdc31p CaM selectively labeled addition <br /> Anti-Karlp antibodies eluted 100 mM glycine, pH 2.5. The pH            10 #Ci/ml [35S]methionine [35S]cysteine (Tran35S-<span id='am-4' about='rdfs:label' typeof='owl:Thing'>label</span>; DuPont, <br /> was immediately adjusted pH 7.5 1 M Tris-HCl, pH 8.0. BSA (0.1           Bad Homburg, Germany) 5 min 37&#194;&#176;C. <br /> m_g/ml)was added affinity-purified anti-Karlp antibodies           Cells harvested centrifugation (3 rain, 14,000 g, 4&#194;&#176;C). The cell <br /> dialyzed phosphate-buffered saline.                                      sediment resuspended 1/10 vol 50 mM Tris-HCl, pH 8, 0.5 mM <br />    Purified GST-N-Nuflp injected goat (Harlow Lane, 1988).        EDTA, 1 mM PMSE 100 ~g/ml lysozyme. The cells lysed three <br /> Purified anti-N-Nuflp antibodies prepared described anti-Karlp       freeze-thawing cycles. Unlysed ceils removed centrifugation <br /> antibodies using purified GST-N-Nuflp coupled CNBr-Sepharose.                 (14,000 g, 4&#194;&#176;C, 15 rain). Cdc31p CaM enriched heating <br />    Goat anti-~-tubulin peptide antibodies prepared follows: pep-       cell extract 5 rain 80&#194;&#176;C. Denatured proteins removed cen- <br /> tide (CMSKNRSSLQSGPLN) corresponding COOH-terminai                        trifugation (14,000 g, 4&#194;&#176;C, 15 min). 90% Cdc31p CaM the <br /> amino acids yeast/~-tubulin coupled BSA m-maleimido-              supernatant. The enriched Cdc31p CaM radiochemically pure. <br /> benzoyl-N-hydroxysuccinimide ester (MBS; Pierce, Rockford, IL). The              The chemical purity Cdc31p CaM &#226;&#8364;&#162;80% estimated by <br /> coupled peptide injected goat recommended Harlow            SDS-PAGE. <br /> Lane (1988). For afffiaity-purification anti-/3-tubulin antibodies, the <br /> /3-tubulin peptide coupled epoxy-activated Sepharose 6B recom- <br /> mended Pharmacia. Anti-/~-tubulin antibodies ehited pep- <br />                                                                                  Interaction Cdc31p CaM Karlp <br /> tide resin 100 mM glycine, pH 2.5. The pH eluted antibodies          Nuflp/Spc110p <br /> was adjusted immediately described anti-Karlp antibodies. The         E. coli extracts containing GST-Karlp, GST-AKarlp, GST-AAKarlp, GST- <br /> anti-~-tubulin antibodies specific for/~-tubulin immunoblots         N-Nuflp GST-C-Nuflp separated SDS-PAGE. The extracts <br /> immunofluorescence.                                                              transferred nitrocellulose membrane electroblotting using a <br />                                                                                  semi-dry transfer cell Bio Pad. Protein binding sites blocked <br /> Immunoelectron Microscopy, Immunofluorescence                                 20 mM Hepes, pH 7.5, 200 mM NaCI, 5% BSA, 0.05% Tween for <br />                                                                                  2 h 20&#194;&#176;C. Membranes incubated buffer A (20 mM <br /> Nuclei Yeast Cells                                                           Hepes, pH 7.5, 200 mM NaCI, 0.05% Tween, 0.1% BSA, 0.1% gelatine, <br /> Immunolectron microscopy yeast cells isolated SPBs per-         1 mM CaCl2) buffer B (20 mM Hepes, pH 7.5, 200 mM NaCl, 0.05% <br /> formed affinity-purified anti-Karlp 12CA5 antibodies (Hiss Diag-         Tween, 0.1% BSA, 0.1% gelatine, 10 mM EGTA)for 1 h 20&#194;&#176;C. Purified <br /> nostics GmbH, Freiburg, Germany) described Preuss et al. (1991)            [35S]Cdc31p (100,000 cpm/#g) [35S]CaM (100,000 cpm//~g) in- <br />  <br />  <br />  <br />  <br /> The Journal Cell Biology, Volume 128, 1995                                    866 <br />  cubated buffer A B 1 h 4&#194;&#176;C. The preincubated Cdc31p and <br /> CaM incubated nitrocellulose membranes buffer A B <br /> for 2 h 20&#194;&#176;C. To remove unbound Cdc31p CaM, membranes were <br /> washed times buffer A B, respectively, 20 rain 20&#194;&#176;C. <br /> The dried membranes autoradiographed using X-ornat AR film <br /> from Kodak. <br />  <br /> Dot Blot Overlay Assay <br /> GST-AKarlp, GST-AKarlp-A, GST-AKarlp-2A, GST-AKarlp-3&amp;, GST- <br /> AKarlp-4A, GST expressed E. coli BL21 (DE3) purified <br /> as described. 50 pmol various GST fusion proteins immobilized <br /> onto nitrocellulose membranes using dot blot apparatus Schleicher <br /> and Schuell (Dassel, Germany). The membrane incubated with <br /> [3sS]Cdc31p buffer A 2 h 20&#194;&#176;C. The membrane washed four <br /> times buffer A 20 min 20&#194;&#176;C. Sections nitrocellulose mem- <br /> branes containing fusion proteins bound [35S]Cdc31p cut out. <br /> The radioactivity determined liquid scintillation counter (LSI801;     Figure L The affinity-purified anti-Karlp antibodies specific. <br /> Beckman, Palo Alto, CA). One sample did contain protein. The            Total yeast extracts prepared described Materials and <br /> radioactivity bound sample considered nonspecific binding. <br /> The samples corrected non-specific binding. All experi- <br />                                                                                 Methods yeast strains BJ5626 (KARLlane 1 ), ESM33 (KAR/, <br /> ments performed triplicates.                                            lane 2), ESM36 (KARl-HA,lane 3), MS2083 (karl-AfT, lane 4) <br />                                                                                 ESM34 (GST-KAR/,lane 5). Proteins separated 10% <br /> Synchronization Yeast Cells Using Strain Y255                                SDS-PAGE transferred nitrocellulose membrane in- <br />                                                                                 cubated affinity-purifiedanti-Karlp antibodies. The immuno- <br /> Strain Y255 carries cdc28-4 allele addition clnl::HlSG           blot developed ECL kit Amersham. <br /> cln2A. The CLN1 CLN3 genes control GAL/promoter <br /> (GALI::CLN1 plasmid p215(LEU2) GALI::CLN3 CLN3 locus) <br /> (T. Schuster, unpublished observation). Y255 grown SC Medium <br /> containing 2% ratiinose 1% galactose mid log phase. The cells       localization studies indirect immunofluorescence and <br /> washed twice water resuspended SC medium 2% raffinose.         immunoelectron microscopy. <br /> After 4 h SC raflinose medium &gt;95 % cells arrested START.        The localization Karlp yeast strain BJ5626 inves- <br /> The cells continued synchronously cell cycle addition 2 %   tigated indirect immunofluorescence. Double-labeling ex- <br /> galactose SC raftinose medium. <br />                                                                                 periments performed afffinity-purified anti-Karlp <br />                                                                                 anti-90-kD antibodies. The monoclonal anti-90-kD an- <br />                                                                                 tibodies used markers SPBs (Rout Kilmartin, <br /> Results                                                                          1990). DNA stained DAPI. As expected SPB <br />                                                                                 components, Karlp 90-kD proteins detected <br /> Karlp Is Associated SPB During Entire                              dots nuclear periphery (Fig. 2 A, com- <br /> Cell Cycle Yeast Saccharomyces cerevisiae.                                   pare anti-Karlp anti-90-kD DAPI). No defined <br /> The yeast KAR/ essential gene required                       Karlp staining observed parts cell. <br /> SPB duplication nuclear fusion (Rose Fink, 1987;                           To confirm nuclear localization Karlp, im- <br /> Conde Fink, 1976). Despite importance, cellular                     munofluorescence experiment repeated isolated <br /> distribution wild-type Karlp established. For                   nuclei (Fig. 2 B). In agreement immunofluores- <br /> this reason, investigated localization wild-type                      cence yeast cells, signal obtained anti-Karlp <br /> Karlp affinity-purified anti-Karlp antibodies using im-                    anti-90-kD antibodies appeared dots at <br /> munofluorescence immunoelectron microscopy.                                 nuclear periphery (Fig. 2 B, compare anti-Karlp and <br />    The specificity antibody-antigen interaction                      anti-90-kD DAPI staining). In 98 % cases (n = <br /> critical success experiments. Affinity-                         1000), Karlp 90-kD signals coincided, indicating an <br /> purified anti-Karlp antibodies prepared described                    association Karlp SPB. In ,o1% double spot of <br /> Materials Methods. In total yeast extract strains                      anti-Karlp anti-90-kD gives single signal other <br /> BJ5626 ESM33 expressing wild-type Karlp,                           antibody. In remaining 1% SPB staining ob- <br /> protein recognized affinity-purified anti-Karlp an-                  tained anti-90-kD anti-Karlp anti- <br /> tibodies (Fig. 1, lanes 1 2). This protein molecular                  bodies. <br /> mass 53 kD predicted MW Karlp (Rose                             The Karlp-/3-galactosidase hybrid proteins showed typi- <br /> and Fink, 1987). The Karlp-HA GST-Karlp fusion pro-                         cal cell cycle-dependent behavior (Vallen et al., 1992b). Af- <br /> teins strains ESM36 (lane 3) ESM34 (lane 5)                       ter SPB duplication, hybrid proteins as- <br /> have molecular masses 56 79 kD, respectively. In                         sociation SPBs, usually SPB <br /> agreement prediction, proteins molecu-                     enters bud (Vallen et al., 1992b). We investigated <br /> lar masses detected extracts ESM36                             wild-type Karlp associated SPB in <br />  ESM34. A small Karlp detected                            cell cycle-dependent manner. At first, percentage of <br />  preparations extracted ESM36 probably reflects                      SPBs monopolar, short long spindles, de- <br />  proteolytic degradation Karlp-HA sample prepara-                     tected anti-Karlp anti-90-kD antibodies, were <br />  tion. Strain MS2083 carries karl-Al7 <span id='am-85' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-86' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-161' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span>mutation</span> (Vallen                      determined (Table II). Most (&gt;95%) SPBs co- <br />  et al., 1992b; 1994). As expected deletion, anti-                 stained anti-Karlp anti-90-kD antibodies inde- <br />  Karlp antibodies detected 49-kD protein extracts                       pendent cell cycle stage yeast cells. In few <br />  MS2083 (lane 4). These results demonstrate anti-                      cells colocalization observed (Table II). Second, we <br />  Karlp antibodies highly specific Karlp suitable                    synchronized yeast cultures determined distribution <br />  <br />  <br />  <br />  Spang et al. Karlp, Cdc31p-binding Protein SPB Half Bridge             867 <br />                                                                                                                    Figure 2. Karlp associated <br />                                                                                                                   SPB. Immunotiuores- <br />                                                                                                                   cence microscopy whole <br />                                                                                                                   yeast cells (,4) isolated nu- <br />                                                                                                                   clei (B). (A) Whole yeast cells <br />                                                                                                                   strain BJ5626 fixed <br />                                                                                                                   stained affinity- <br />                                                                                                                   purified rabbit anti-Karlp and <br />                                                                                                                   monoclonal mouse anti-90-kD <br />                                                                                                                   antibodies. (B) Yeast nuclei <br />                                                                                                                   strain BJ5626 incu- <br />                                                                                                                   bated afffinity-purified <br />                                                                                                                   anti-Karlp antibodies and <br />                                                                                                                   monoclonal 90-kD antibodies. <br />                                                                                                                   Secondary antibodies used in <br />                                                                                                                   A B described in <br />                                                                                                                   Materials Methods. DNA <br />                                                                                                                   stained DAPI. Mag- <br />                                                                                                                   nification A as <br />                                                                                                                   B. Bar, 5/~m. <br />  <br />  <br /> of Karlp indirect immunofluorescence. To exclude possi-                      antibodies stage cell cycle. Cells cdcl5 were <br /> ble artifacts, yeast cells synchronized different                   shifted permissive conditions, cells <br /> methods, using cdc15 mutant strain Y255. Since                      continued cell cycle. After release cell cycle <br /> both approaches yielded result, data ob-                      block, samples taken 30 min localization <br /> tained cdc15 cells shown (Fig. 3). Ceils cdcl5                  Karlp determined indirect immunofluorescence. <br /> arrest uniformly non-permissive temperature mito-                     Karlp associated SPB yeast cells buds <br /> sis duplicated SPB long mitotic spindle (Fig. 3,                     (Fig. 3, Gl phase cell cycle, 30 min temper- <br /> 0 min). Clearly, SPBs stained anti-Karlp                       ature shift), small- (S-phase, 60 min), medium- (G:, 90 <br />                                                                                 min), large-budded cells (mitosis, 120 rain). These <br /> Table II. Distribution Karlp 90-kD SPB                               results strongly suggest Karlp constitutive compo- <br /> Component Cell Cycle                                                 nent yeast SPB. <br />  <br />                                                                                 Karlp Is Component Half Bridge SPB <br />                                                                                 To understand function SPB components the <br />                                                                                 structure SPB, important determine associa- <br /> Number cells investigated              74       73        61        110 <br />                                                                                 tion SPB components substructures organelle. <br /> 1 dot cell <br />   colocalization Karlp/90 kD         100%      47%        2%        1% <br />                                                                                 At structures SPB detectable electron <br /> 2 dots cell                                                                 microscopy-outer, inner, central plaque, intermediate <br />   colocalization Karlp/90 kD           -       49%      92%        99%       central line, cytoplasmic nuclear half <br /> Partial colocalization                    -        3%       5%         0%       bridge bridge, satellite, connecting fibers between <br />   Karlp/90 kD                                                                inner central plaque. Despite importance, sub- <br />   (1 dot colocalization                                                localization SPB components- Nuflp/Spc110p, <br />   1 dot colocalization)                                                 90-kD component, Cdc3 l p - h v e determined by <br /> No coloealization                          0%       1%       1%        0%       immunoelectron microscopy (Rout Kilmartin, 1990; <br />   Karlp/90 kD                                                                Kilmartin et al., 1993; Spang et al., 1993). <br /> An early logarithmic growing culture yeast strain BJ5626 prepared       We studied localization Karlp immunoelec- <br /> immunofluorescence described Materials Methods stained       tron microscopy using isolated SPBs. Enriched fractions of <br /> anti-Karlp anti-90-kD antibodies. The DNA visualized DAPI. <br /> SPB staining appeared dots dependent cell cycle stage    SPBs contain 500x SPBs volume compar- <br /> the yeast cell (also Figs. 2 3).                                         ison yeast cells, making easier obtain <br />  <br />  <br />  <br />  <br /> The Journal Cell Biology, Volume 128, 1995                                    868 <br />  Figure 3. Karlp associated SPB entire cell cy-   Figure 4. Karlp cofractionates SPBs. A cell lysate strain <br /> cle. Strain Y49 (cdc15-1) grown YPD 23&#194;&#176;C mid-log           BJ5626 fractionated 100,000 g supernatant sediment, <br /> phase. The culture shifted 37&#194;&#176;C &gt;90% ceils     isolated nuclei, enriched SPBs (sucrose Percoll gradient). <br /> were arrested large-budded cells. The arrested cells continued       Equal amounts (10/zg) protein lane analyzed SDS- <br /> in cell cycle decreasing incubation temperature 23&#194;&#176;C   PAGE subsequent immunoblotting using primary antibodies <br /> (t = 0). Samples taken 30 rain analyzed im-           directed against: (A) Cdc31p, (B) Nuflp/Spell0p, (C) 90-kD SPB <br /> munofluorescence anti-Karlp antibodies phase contrast          component, (D)/~-tubulin, (E) Karlp, (F) nucleolar pro- <br /> microscopy. DNA stained DAPI. Only representative          teins Noplp Nop2p. The immunoblots developed de- <br /> cell shown. However, &gt;85 % cells indicated pheno-     scribed Fig. 1. <br /> type. Bar, 5 ~m. <br />  <br /> a representative view localization SPB component.           tions containing SPBs (sucrose Percoll gra- <br /> However, important establish SPB compo-              dient purified SPBs). The tubulin decreased at <br /> nent does disassemble SPB               enrichment nuclei. This agreement with <br /> the enrichment procedure. Therefore, tested                  observation purified nuclei contain no <br /> Karlp cofractionates enriched preparations SPBs.                microtubules, microtubules lost the <br /> Equal amounts total protein cell lysate, 100,000 g            isolation nuclei (Spang et al., 1993). Tubulin was <br /> supernatant sediment fractions, isolated nuclei, su-                strongly enriched SPBs sucrose gradient, <br /> crose Pereoll gradient-enriched SPBs separated              expected SPB-associated component, partially <br /> SDS-PAGE. The distribution SPB components,                     separated SPBs Percoll gradient. This reflects <br /> Cdc31p (Fig. 4 A), Nuflp/Spcll0p (Fig. 4 B), 90-kD                  decrease length microtubules associated the <br /> SPB component (Fig. 4 C) determined markers                  SPBs sucrose comparison SPBs Per- <br /> the enrichment SPBs. In addition, ~tubulin (Fig. 4 D)            coil gradient (data shown). Noplp Nop2p most <br /> two nucleolar proteins, Noplp Nop2p (Jansen et al.,                 strongly enriched isolated nuclei, expected pro- <br />  1993) (Fig. 4 F), detected immunoblotting. As             teins nucleolus. The concentration proteins <br /> we expected, SPB components Nuflp/Spcll0p, 90-kD                    subsequently decreased increasing purity SPBs, <br /> protein Cdc31p strongly enriched frac-             indicating specific enrichment SPBs. Karlp progres- <br />  <br />  <br />  <br /> Spang et al. Karlp, Cdc31p-binding Protein SPB Half Bridge     869 <br />                                                                                                                Figure 5. Karlp compo- <br />                                                                                                               nent half bridge the <br />                                                                                                               SPB. Immunoelectron micros- <br />                                                                                                               copy isolated SPBs (A I) <br />                                                                                                               yeast cells (J L). <br />                                                                                                               (A-E) SPBs purified <br />                                                                                                               strain BJ5626 la- <br />                                                                                                               beled affinity purified <br />                                                                                                               anti-Karlp antibodies. Single <br />                                                                                                               SPBs shown (A-C, and <br />                                                                                                               E). (D) Mother daughter <br />                                                                                                               SPBs connected bridge. <br />                                                                                                               (F-I) SPBs isolated from <br />                                                                                                               strain ESM36 (KARl-HA)and <br />                                                                                                               labeled 12CA5 mono- <br />                                                                                                               clonal antibodies.        (J-L) <br />                                                                                                               Whole cells ESM36 were <br />                                                                                                               labeled 12C.A5 antibod- <br />                                                                                                               ies. (J) Nucleus SPB. (K) <br />                                                                                                               Enlargement J. (L) A single <br />                                                                                                               SPB nuclear pore. b, <br />                                                                                                               bridge; c, central plaque; C, <br />                                                                                                               cytoplasm; h, half bridge; i, <br />                                                                                                               inner plaque; m, microtubnles; <br />                                                                                                               N, nucleus; o, outer plaque. <br />                                                                                                               The arrow J indicates the <br />                                                                                                               position central plaque <br />                                                                                                               SPB nuclear enve- <br />                                                                                                               lope. The asterisk J L <br />                                                                                                               indicates position nu- <br />                                                                                                               clear pore. Bars: (E) 31 nm; <br />                                                                                                               (1) 62 nm; (J) 65 nm. (A-H <br />                                                                                                               K, L) mag- <br />                                                                                                               nification E. <br />  <br />  <br /> sively enriched increasing purity SPBs be-            bridge b r d g e - w e r e clearly detectable (Fig. 5, A-E). <br /> haved like SPB components Cdc3 lp, Nuflp/Spc110p             No cytoplasmic nuclear microtubules associated <br /> and 90-kD protein. We conclude result Karlp            SPBs preparation. Two gold particles <br /> cofractionates purified preparations SPBs.                    associated electron dense structure-the half <br />    The localization Karlp investigated immunoelec-          b r d g e - n e x t central plaque (Fig. 5, A - C n d E). After <br /> tron microscopy ultra-thin sections enriched SPBs             START cell cycle, SPB duplicates two <br /> using affinity-purified anti-Karlp antibodies. The substruc-          SPBs connected bridge. The bridge appeared <br /> tures S P B - o u t e r , central, inner plaque half   electron micrographs electron dense layer connect- <br />  <br />  <br />  <br />  <br /> The Journal Cell Biology, Volume 128, 1995                         870 <br />  ing central plaques mother daughter SPB (Fig.          Karlp associated cytoplasmic half <br /> 5 D). Gold particles localized cytoplasmic         bridge. <br /> of bridge (Fig. 5 D). Only ,o10% isolated SPBs <br /> were labeled anti-Karlp antibodies. In cases, the <br />                                                                       Cdc31p Interacts Karlp Nuflp/SpcllOp <br /> half bridge bridge stained. No staining struc-        Mutants kar/(Rose Fink, 1987) cdc31 (Byers, <br /> tures observed. One possible explanation poor             1981a,b) similar phenotypes; arrest large bud- <br /> efficiency SPB staining anti-Karlp antibodies        ded cells single, enlarged SPB lacking satellite. This <br /> the fixation-sensitivity Karlp epitopes. In agreement         finding suggests proteins act same <br /> this conclusion, observed percentage SPBs              pathway SPB duplication, interact. How- <br /> stained immunofluorescence yeast cells strongly de-             ever, direct interaction Cdc3 lp Karlp seemed <br /> creased increasing fixation time (data shown).               unlikely, proteins localized differ- <br />     To confirm association Karlp half bridge,         ent substructures SPB (Vallen et al., 1992b; Spang et <br /> we repeated immunoelectron microscopy epi-                al., 1993). Our current studies, indicate Karlp <br /> tope-tagged Karlp-HA protein. A gene fusion consisting                Cdc31p associated half bridge SPB, <br /> of KAR/and sequences coding hemagglutinine              modify picture. <br /> epitope (YPYDVPDYA) constructed. The plasmid                          Cdc31p shows striking homology CaM (Baum et al., <br /> coding KARl-HA (pBM12) transformed                   1986). The interaction CaM proteins in- <br /> yeast strain UFM2 (KAR1/Akarl::HIS3). The strain UFM2                 vestigated so-called overlay assay (Glenney and <br /> (pBM12) sporulated, viability 20 tetrads           Weber, 1980). Radiolabeled CaM incubated filter- <br /> determined. Colonies spores haploid,                  immobilized proteins. The interaction assayed by <br /> His+ Ura &#195;&#183; obtained, indicating strains           autoradiography. To identify proteins interact with <br /> carried Akarl::HIS3 disruption URA3-based                 Cdc31p, performed overlay assay [35S]Cdc31p. <br /> plasmid pBM12. This strain designated ESM36. Since                Cdc31p selectively labeled T7 (Tabor and <br /> KAR/is essential viability (Rose Fink, 1987)          Richardson, 1985), purified described Mate- <br /> chromosomal KAR/gene ESM36 disrupted, KARI-HA                   rials Methods. [3~S]Cdc31p incubated proteins <br /> on plasmid pBM12 provide KAR/function. Immuno-                   total yeast extract isolated nuclei (Fig. 6 A). One <br /> blotting cell extracts ESM36 anti-Karlp (Fig. 1,           protein interacting [35S]Cdc31p molecular mass <br /> lane 3) 12CA5 (data shown) antibodies revealed            53 kD; suggesting Karlp. To test whether <br /> Karlp-HA fusion protein expected molecular mass               [35S]Cdc31p binds recombinant Karlp, expressed <br />  ,,o58 kD. In wild-type control (YPH499), however,                GST-KAR/and truncations GST-KAR/in E. coli. Recently, <br />  Karlp (molecular mass 53 kD) detected anti-          reported CaM binds COOH terminus of <br />  Karlp 12CA5 antibodies. In addition, obtained          Nuflp/Spe110p (Geiser et al., 1993). To test Cdc31p <br />  SPB staining indirect immunofluorescence using ESM36               interacts Nuflp/Spcll0p, expressed NH2- <br />  cells 12CA5 antibodies. A wild-type strain did           COOH-terminal Nuflp/Spcll0p fusion pro- <br />  signal 12CA5 antibodies (data shown). Taken              teins GST E. coli ( GST-N-NUF1 GST-C-NUF1). <br />  together, results indicate Karlp-HA fusion pro-        Fig. 6 B shows Coomassie blue stained gel E. coli <br />  tein expressed ESM36 cells, provides Karlp function,            extracts containing GST-Karlp GST-Nuflp fusion <br />  localizes SPB.                                           proteins. <br />     We enriched SPBs ESM36 cells determined                  E. coli extracts various GST-Karlp GST- <br />  localization Karlp-HA immunoelectron microscopy                 Nuflp fusion proteins (Fig. 6 B) transferred nitro- <br />  using 12CA5 antibodies (Fig. 5, F-l). In experiment,         cellulose membranes (Fig. 6, C D). After blocking the <br />  embedded sectioned SPBs contained microtubules.             protein binding sites membranes, blots incu- <br />  More 50% SPBs labeled 12CA5 anti-             bated [35S]Cdc31p (Fig. 6 C) [35S]CaM (Fig. 6 D) <br />  bodies. The gold particles associated             presence (+Ca 2&#195;&#183;) absence (+EGTA) Ca 2+. <br />  half bridge, confirming results anti-Karlp anti-         CaM Saccharomyces cerevisiae used parallel to <br />  bodies. SPBs wild-type strain stained            Cdc3 lp control. Free Ca2+ removed chela- <br />  12CA5 antibodies (data shown).                                tor EGTA experiment determine <br />     To confirm localization Karlp-HA yeast             binding specificity Cdc31p CaM Ca 2+- <br />  cells, sections cells ESM36 labeled 12CA5             dependent. Cdc31p bound GST-Karlp GST-AKarlp <br />  antibodies (Fig. 5, J-L). The SPBs sectioned         GST-AAKarlp (a truncation COOH- <br />  central plaque SPB clearly visible discontinuity       terminal half Karlp) presence Ca2+ (Fig. 6 C, <br />  nuclear envelope. Also visible micrograph         +Ca2+). In addition, interaction detected the <br />  half bridge electron-dense extension central              C-terminal (GST-C-Nuflp), NH2-terminal, part <br />  plaque nuclear envelope. The outer inner plaques            Nuflp/Spcll0p (GST-N-Nuflp). CaM specifically inter- <br />  detected procedure used immunoelectron             acted COOH-terminal Nuflp/Spcll0p the <br />  microscopy. Most yeast cells contained               presence Ca :+ interacted NH2- <br />  gold particles randomly distributed cell.               terminal Nuflp/Spcll0p different GST- <br />  Clusters gold particles observed          Karlp constructs (Fig. 6 D, +Ca2&#195;&#183;). As previously de- <br />   1% cells. In cases, gold particles        scribed (Geiser et al., 1993), interaction CaM with <br />   central plaque, half bridge          GST-C-Nuflp observed absence Ca2&#195;&#183; (Fig. <br />   SPB. The gold particles directed cytoplas-            6 D, +EGTA). Cdc3 lp bound proteins absence <br />   mic nuclear envelope (Fig. 5, J-L) suggesting        Ca 2+ (Fig. 6 C, +EGTA). The GST-Karlp constructs, <br />  <br />  <br />  <br /> Spang et al. Karlp, Cdc31p-binding Protein SPB Half Bridge    871 <br />                                                                           A <br />                                                                                                                                                                                      Binding of <br />                                                                                     &quot;1                                                                            433                 Cdc31 p <br />                                                                         GST - - L - ~ ~ . . \ . . . . . . . . \ \ . , . \ ~ . . . \ \ \ \ . , . \ ~                 GST-KarI p <br />  <br />                                                                                     1                                                                       386 <br />                                                                         GST - - t           ~        \       \      -       ,                xxx-~\\-~\-,. <br />                                                                                                                                                        \x~.~.       GST-&amp;Karlp <br />  <br />                                                                                     1                                           237 <br />  <br />  <br />  <br />                                                                                                                                 237                         386 <br />                                                                                                                         GST- - ~N~-&apos;..~..~&apos;.~                      GST-/&apos;,Karlp-A <br />  <br />                                                                                                                                 237                   350 <br />                                                                                                                         GST--~,-,~                                 GST-ZxKarlp-2A <br />  <br />                                                                                                                                 237 272 <br />                                                                                                                         GST- L ~                                   GST-AKarlp-3A <br />  <br />                                                                                                                             237 255 <br />                                                                                                                       GST ~                                        GST-~Karl p-4tx <br />  <br />  <br />  <br />  <br /> Figure 6. Cdc31p interacts Karlp Nuflp/Spcll0p. (A) A <br /> total yeast extract isolated nuclei strain BJ5626 separated <br /> on 12% SDS-PAGE transferred nitrocellulose mem- <br /> brane. The membrane incubated [35S]Cdc31p de- <br /> scribed Materials Methods. (B) GST-Karlp GST- <br /> Nuflp/Spcll0p fusion proteins expressed E. coli BL21 (DE3). <br /> The gel stained Coomassie blue. (CandD) Overlay assays <br /> of samples shown B using (C) [3sS]Cdc31p (D) lasS]CaM in <br /> the presence Ca2+ EGTA. The dried membranes ex- <br /> posed autoradiography. <br />                                                                         Figure 7. Identification Cdc31p-binding region Karlp. (,4) <br />                                                                         Various GST-KAR/ gene fusions constructed described <br />                                                                         Materials Methods using restriction sites KAR/cod- <br /> GST-N-Nuflp GST-C-Nuflp E. coli pro,               ing region. (B) Quantitation Cdc31p-binding Karlp-frag- <br /> tein labeled [3~S]Cdc31p Ca 2&#195;&#183; removed                 ments. Purified GST-AKarlp, GST-i~Karlp-A, GST-AKarlp-2,% <br /> by chelator EGTA (Fig. 6 C, +EGTA). The Ca2+-free                   GST-AKarlp-3A, GST-AKarlp-4A, GST blotted nitro- <br /> [35S]Cdc31p did bind GST (data shown), suggest-              cellulose membrane described Materials Methods. The <br /> ing Cdc31p interacted Karlp Nuflp portions            membrane incubated [3sS]Cdc31p. Sections mem- <br /> of GST-Karlp GST-Nuflp fusion proteins ab-               brane containing fusion proteins bound [35S]Cdc31p were <br /> sence Ca 2+.                                                         cut out. The radioactivity determined liquid scintillation <br />                                                                         counter. The experiment performed triplicates. (C) The po- <br />    Since Cdc31p interacts GST-AKarlp GST- <br />                                                                         tential Cdc3 lp-binding peptide Karlp (amino acids 239-257 of <br /> AAKarlp (Fig. 6 C), Cdc31p bind COOH-                       Karlp) comparison CaM-binding domains. M13: CaM bind- <br /> terminal half Karlp. Further deletions region             ing peptide rabbit skeletal muscle myosin light chain kinase <br /> Karlp constructed determine binding site Cdc-            (Blumenthal et al., 1985); RL17: Amino acid sequence residues <br /> 3 lp (Fig. 7 A). GST-AKarlp, GST-AKarlp-A, GST-AKarlp-                  329-345 ~/subunit rabbit skeletal muscle phosphorylase <br /> 2A, GST-AKarlp-3A, GST-AKarlp-4A GST puri-                     kinase (Reimann et al., 1984); RS20: High-affinity CaM binding <br /> fied described Materials Methods. GST-Karlp               peptide chicken myosin light chain kinase (Lukas et al., 1986). <br /> not used experiment protein insoluble <br /> in E. coil Equal molar amounts fusion protein were <br />  <br />  <br />  <br />  <br /> The Journal Cell Biology, Volume t28, 1995                            872 <br />                                                                          Table IlL SPB Staining Yeast Cells <br />                                                                         Strain                Numberof SPB&apos;s                Stained SPB&apos;s <br />                                                                         YPH499                      16                           8 <br />                                                                         ESMll5                      18                           0 <br />  <br />  <br /> Figure 8. Karlp associated SPB cdc31 cells. Strain <br /> ESM56 grown SM Medium containing adenine, lysine, tryp-          rested ESM56 cells (Fig. 8). An identical result obtained <br /> tophan uracil. Cells diluted SC Medium containing         cdc31-1 cells (Byers, 1981b) shifted non-permis- <br /> 2 mM methionine repress expression CDCM. The culture          sive temperature (data shown). Therefore, concluded <br /> was incubated 8 h 30&#194;&#176;C. No Cdc31p detectable      Cdc3 lp required localization Karlp with <br /> incubation period immunoblotting (data shown). ESM56             SPB. Alternatively, Cdc31p play direct role in <br /> cells fixed stained affinity purified rabbit anti-   localizing Karlp SPB lost turnover. <br /> Karlp monoclonal mouse anti-90-kD antibodies. DNA                  We determined Cdc3 lp associated the <br /> stained DAPI. Bar, 5 #m.                                           SPB karl cells. A strain, ESMll5, constructed in <br />                                                                         KAR/is control MET3 promoter. Eight <br />                                                                         hours addition methionine culture ESM- <br /> blotted nitrocellulose membrane incubated                 115, cells arrested uniformly large bud single <br /> with [3sZ]Cdc31p. Pieces nitrocellulose membrane con-                SPB. No Karlp detectable immunoblotting cell <br /> taining fusion proteins bound Cdc31p ex-              extract ESMll5 growth methionine-containing <br /> cised assayed [35S]Cdc31p. Two times Cdc31p                 medium (data shown). <br /> was bound GST-AKarlp GST-AKarlp-A, GST-                         Cells ESM115 incubated methionine-containing <br /> AKarlp-2A GST- AKarlp-3A (Fig. 7 B). The binding                    medium prepared immunoelectron microscopy <br /> efficiency decreased additional 17 amino                anti-Cdc31p antibodies described Spang et al. <br /> acids GST-AKarlp-3A deleted (GST-AKarlp-4A),                    (1993). As control, parent strain YPH499 grown under <br /> suggesting Cdc3 lp-binding domain Karlp              conditions labeled parallel. The SPB cells <br /> part removed GST-AKarlp-4A. Since binding [35S]-               YPH499 stained half bridge (Spang et al., <br /> Cdc31p GST observed, interaction GST-                    1993; Table III). In contrast YPH499, SPB staining <br /> Karlp-4A depend Karlp portion fusion                 detected cells ESMll5 (Table III). The levels of <br /> protein. The folding GST responsible                Cdc31p lysates ESMll5 YPH499 approxi- <br /> lower binding efficiency GST-AKarlp-A, GST-AKarlp-2A                 mately (as tested immunoblotting), indicating <br /> and GST-AKarlp-3A compared GST-AKarlp. Therefore,                    Cdc31p degraded absence Karlp (data <br /> we heat-denatured various GST-Karlp proteins                   shown). This result suggests binding Cdc3 lp to <br /> 0.2% SDS bound GST-Karlp proteins denatur-                SPB requires Karlp structure SPB <br /> ing conditions nitrocellulose membrane. The Cdc3 lp-             KAR/mutant changed way Cdc3 lp <br /> binding assay repeated. A similar result              binding eliminated. A similar result reported Big- <br /> obtained (data shown), indicating folding               gins Rose (1994), using temperature sensitive strain <br /> GST-Karlp proteins did influence binding Cdc3 lp.            MS2083 (karl-Al7). <br />    The comparison extended Cdc3 lp-binding region of <br /> Karlp-4A CaM-binding peptides reveals sequence <br />  conserved features (Fig. 7 C) which, however, differs             Discussion <br />  positions CaM binding sequences. <br />                                                                         Localization Karlp Protein <br /> Karlp Associated SPB Absence                      Despite important role centrosome phase <br /> Cdc31p, Localization Cdc31p                      life cycle eukaryotic cells, relatively little known <br /> SPB Is Dependent Karlp                                               molecular structure cell cycle regulation. This <br /> We tested interaction Karlp SPB              valid yeast Saccharomyces cerevisiae, cen- <br /> dependent Cdc3 lp. CDC31 strain ESM56 con-               trosomal functions provided SPB (Byers, 1981a, <br /> trol methionine-repressible MET3 promoter (Alber-                b). For example, sublocalization SPB pro- <br /> mann, K., U. Faclder, A. Spang, K. Grein, E. Schie-                 teins reported date; Nuflp/Spcll0p, 90-kD pro- <br /> bel, manuscript preparation). The wild-type CDC31                 tein Cdc31p (Kilmartin et al., 1993; Rout Kilmartin, <br /> ESM56 disrupted HIS3 gene MET3-CDC31                    1990; Spang et al., 1993). The location proteins <br /> is integrated LEU2 locus (Table I). The addition            SPB outlined Fig. 9 A. <br /> methionine culture ESM56 causes total depletion                Karlp potential SPB component. Karlp functions <br /> of Cdc31p followed cell cycle arrest. Eight hours            karyogamy mating yeast cells SPB duplica- <br /> the addition methionine culture ESM56, Cdc3 lp               tion mitosis (Conde Fink, 1976; Rose Fink, <br /> was detectable immunoblotting anti-Cdc3 lp anti-             1987). Since Karlp essential, important establish <br /> bodies cell lysate (data shown). The localization           subcellular localization. Karlp-/~-galactosidase fusion <br /> Karlp cells ESM56 investigated depletion             proteins associated SPB cell cycle- <br /> Cdc3 lp indirect immunofluorescence anti-Karlp an-              dependent manner. Furthermore, hybrid pro- <br /> tibodies. Karlp associated SPB cell cycle ar-           teins localized outer plaque SPB (Vallen et al., <br />  <br />  <br />  <br /> Spang et al. Karlp, Cdc31p-bindingProteinof SPB HalfBridge         873 <br />                                                                                                      Figure 9. (A) Schematic dia- <br />                                                                                                     gram showingthe localization <br />                                                                                                     Karlp Cdc31p relative <br />                                                                                                     known SPB compo- <br />                                                                                                     nents. (B) A model in- <br />                                                                                                     teraction Cdc31p Karlp <br />                                                                                                     unidentified protein <br />                                                                                                     Xp cytoplasmic of <br />                                                                                                     half bridge. For descrip- <br />                                                                                                     tion text. <br />  <br />  <br /> 1992b). Lately, question raised be-      bridge comprised subcompartments, nuclear <br /> havior Karlp-fl-galactosidase fusion proteins reflects     cytoplasmic, differ composition. At <br /> that wild-type Karlp (Biggins Rose, 1994). In pa-     domains Karlp necessary localization <br /> per, Karlp behaves quite differently        half bridge. The COOH-terminal membrane anchor <br /> the Karlp-fl-galactosidase fusion proteins. We demonstrate        targets Karlp-fl-galactosidase fusion proteins nuclear <br /> for time Karlp permanent component     envelope (Fig. 9 B [/]; Vallen et al., 1992b). The center of <br /> half bridge SPB. Taken together, lines evidence    Karlp (amino acids 190-259) direct Karlp-fl-galactosi- <br /> support conclusion: (a) Karlp cofractionated           dase fusion proteins SPB (Fig. 9 B [I/]). Karlp fusion <br /> highly enriched preparation SPBs (Fig. 4). (b) Karlp       proteins containing central domain mistargeted <br /> associated SPB entire cell cycle, re-      outer plaque SPB (Vallen et al., 1992b). The <br /> vealed indirect immunofluorescence (Figs. 2 3). (c)        NH2-terminus Karlp (Fig. 9 B [lift) functions in <br /> The half bridge bridge isolated SPBs seen im-        karyogamy (VaUen et al., 1992a) likely exposed <br /> munoelectron microscopy labeled affinity purified        cytoplasm. Our working model Karlp first <br /> antibodies (Fig. 5, A-E). (d) Epitope tagged, functional          directed cytoplasmic nuclear envelope <br /> Karlp associated half bridge shown        hydrophobic membrane anchor. In second step, <br /> immunoelectron microscopy 12CA5 monoclonal anti-             Karlp targeted half bridge SPB <br /> bodies using yeast cells (Fig. 5, J-L) isolated         interaction SPB component (Fig. 9 <br /> SPBs (Fig. 5, F-l).                                               B; Xp). Whether component Cdc31p clear. The <br />    Because gold particles immunoelectron micros-       observation Karlp associated SPB ab- <br /> copy directed cytoplasmic nu-         sence Cdc3 lp (Fig. 8) argues role Cdc3 lp in <br /> clear envelope (Fig. 5, D J-L), Karlp associated       directing Karlp SPB. However, Cdc3 lp play di- <br /> with cytoplasmic half bridge bridge sub-   rect role localizing Karlp SPB lost after <br /> structure SPB (Fig. 9 A). This suggests half      shifting cdc31 cells non-permissive conditions. <br />  <br />  <br />  <br /> The Journal Cell Biology, Volume 128, 1995                     874 <br />    Wild-type Karlp associated SPB                   We compared amino acids 230-260 Karlp pub- <br /> entire yeast cell cycle (Fig. 3), Karlp-/~-gaiac-          lished CaM-binding peptides. Amino acids 239-257 of <br /> tosidase fusion proteins not. We suggest Karlp          Karlp features common CaM-binding <br /> permanent component half bridge bridge               peptides (Fig. 7 C). The positively charged amino acids at <br /> SPB. The Karlp seen immunoelectron micros-              positions I, 2, 3, 12, 16, hydrophobic amino acids <br /> copy half bridge bridge SPBs isolated        positions 13 14 present 2 3 CaM- <br /> from unsynchronized, logarithmic growing yeast. Since              binding peptides (Fig. 7 C). The acidic amino acid posi- <br /> the Karlp-/~-galaetosidase fusion proteins mistargeted         tion 7 basic amino acids positions 9, 18, 19 <br /> the outer plaque SPB, surprising           coincided CaM-binding peptides. In <br /> differ wild-type Karlp cell cycle behavior.             contrast CaM-binding peptides, potential Cdc31p- <br />                                                                       binding site contained acidic amino acids not <br />                                                                       CaM-binding motifs determine the <br /> Interaction Cdc31p Karlp                                      specificity interaction Cdc31p. Furthermore, <br /> Mutants KAR/ (Rose Fink, 1987) CDC31                  analysis potential Cdc31p-binding peptide <br /> (Byers, 1981a,b) exhibit similar <span id='am-7' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-8' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span>phenotype</span>; arrest          method Rost et al. (1993) predicted high probabil- <br /> budded cells single, enlarged SPB lacking satellite.         ity alpha-helical conformation. This conforma- <br /> This finding suggests proteins act           tion CaM-binding peptides (O&apos;Neil et al., 1987). <br /> pathway SPB duplication. A direct interaction Karlp                 While manuscript preparation, Biggins and <br /> and Cdc31p unlikely, Karlp-fl-galactosidase              Rose (1994) reported interaction Cdc31p Karlp <br /> and Cdc31p localized different substructures           using similar approach. The Cdc31p-binding domain <br /> SPB complex. From studies, clear              localized amino acids 187-299 Karlp including <br /> Karlp Cdc31p components cytoplasmic               portion Karlp mapped Cdc31p-binding <br /> of half bridge (Spang et al., 1993, Fig. 5). We         region (amino acids 237-255). It remains unclear why <br /> used vitro assay successfully used            Karlp-/~-galactosidase fusion proteins encoded plasmids <br /> study interaction CaM target proteins (Glenney            pMR404 (amino acids 1-259 Karlp) pMR1850 (amino <br /> and Weber, 1980) investigate Cdc31p Karlp              acids 187-259) did interact Cdc31p (Biggins and <br /> directly interact. Our findings clearly indicate Cdc31p          Rose, 1994). These fusion proteins expressed yeast <br /> interacts vitro COOH-terminal half Karlp               enriched immunoprecipitation. Possibly, fusion <br /> (Figs. 6 7). In addition, Cdc31p binds COOH ter-           site /~-galactosidase COOH terminus the <br /> minus Nuflp/Spell0p, contains binding site             Cdc31p-binding motif interferes Cdc3 Ip-binding. Fur- <br /> CaM (Geiser et al., 1993). Whether Cdc31p binds                ther, Biggins Rose (1994) did observe Ca2+-depen- <br /> CaM-binding site Nuflp/Spcll0p               dence Cdc3 lp-binding, reported increase <br /> protein contains additional Cdc31p-binding motif re-               background binding EGTA present. This dis- <br /> mains determined. The significance interaction          crepancy explained different methods used for <br /> is clear, especially Cdc31p Nuflp/Spc110p              labeling Cdc3 lp studies. We specifically la- <br /> are associated different substructures SPB (Fig.          beled Cdc31p vivo using T7 system, purified <br /> 9 A). However, CaM did bind Karlp, indicating                35S-labeled protein. Biggins Rose (1994) labeled <br /> different substrate specificity Ca2+-binding pro-           purified Cdc31p sulphur labeling kit adds 35S to <br /> teins. The Ca2+ dependence interaction CaM               free amino groups modifies Cdc31p. <br /> Cdc31p substrates different. While CaM did                  The question remains, Cdc3 lp Karlp interact <br /> not bind protein absence Ca2+ (Fig. 6 D,              vivo. We able demonstrate interaction <br /> Geiser et al., 1993), Cdc31p interacted additional pro-           Karlp Cdc31p immunoprecipitation anti- <br /> teins (one E. coli protein, NH2 terminus Nuflp/Spc110p              Cdc31p anti-Karlp antibodies (A. Spang, unpublished ob- <br /> and Karlp, Abb. 6C) Ca2+ removed EGTA.                     servations). The reasons twofold. The com- <br /> Although studied Ca2+-independentinterac-              plex containing Karlp Cdc3 lp disrupted during <br /> tions Cdc31p further, observations suggest             extraction SPBs. Alternatively Karlp Cdc3 lp may <br /> binding specificity Cdc3 lp regulated Ca2+. The pro-          interact transiently short period cell cy- <br /> teins interacted Cdc31p absence Ca2&#195;&#183;               cle. Karlp potential p34 c&#194;&#176;c2~ phosphorylation site <br /> may binding sites recognized Ca2+-              (TPTK; Moreno Nurse, 1990) amino acids 294-297 <br />  free Cdc3 lp.                                                         involved regulation. Genetic studies <br />    We localized core Cdc3 lp-binding site           Vallen et al. (1994) identified CDC31 high copy num- <br /> Karlp amino acids 237 255 (Fig. 7, A B)             ber ectrogenic suppressor temperature sensitive mu- <br /> indicated binding Cdc3 lp GST-ZkKarl-4A. The              tation KARL While suggests interaction Cdc31p <br /> total Cdc3 lp-binding region Karlp probably larger          Karlp, cdc31 alleles suppressed complete dele- <br /> the 18 amino acids AKarlp-4A. This suggested              tion KAR/(VaUen et al., 1994), favoring bypass mecha- <br />  observation NH2-terminal (AKarlp) COOH-termi-                nism. In summary, considering colocalization Karlp <br />  nal extensions (AKarlp-A, AKarlp-2A zkKarlp-3A)            Cdc3 lp substructure SPB (Fig. <br />  zkKarlp-4A peptide increase efficiencyof Cdc3 lp-binding          5; Spang et al., 1993), vitro interaction Cdc31p and <br />  (Fig. 7 B). We think folding GST inhibits          Karlp (Figs. 7 8; Biggins Rose, 1994) genetic <br />  interaction Cdc31p Karlp, unfolding GST          interaction CDC31 KAR/(Vallen et al., 1994) <br />  SDS did influence binding Cdc31p GST-            likely Cdc31p Karlp interact tran- <br />  Karlp constructs.                                                      siently vivo. <br />  <br />  <br />  <br /> Spang et al. Karlp, Cdc31p-binding Protein SPB Half Bridge   875 <br />     Interestingly, amino acids 235 294 Karlp                             body duplication: Homology product Ca2+-binding proteins. <br />                                                                                      Proc. Natl. Acad. Sci. USA. 83:5512-5516. <br /> deleted affecting viability yeast cells,                   Biggins, S., M. D. Rose. 1994. Direct interaction yeast spindle <br /> deletion amino acids 191-246 caused temperature sen-                            pole body components: Karl p required Cdc31 p localization spin- <br /> sitive phenotype (Vallen et al., 1992a). These deletions in-                         dle pole body. J. Cell Biol. 125:843-852. <br />                                                                                   Blumenthal, D. K., K. Takio, A. M. Edelman, H. Charbonnean, K. Titani, <br /> terfere minimal Cdc3 lp-binding site                          K. A. Walsh, E. G. Krebs. 1985. Identification calmodulin- <br /> identified (amino acids 237-255; Fig. 7 A)                         binding domain skeletal muscle myosin light chain kinase. Proc. Natl. <br /> extended region Biggins Rose (1994; amino acids                               Acad. Sci. USA. 82:3187-3191. <br />                                                                                   Bradford, M. M. 1976. A rapid sensitive method quantitation of <br /> 190-299 Karlp). This finding raises question,                         microgram quantities protein utilizing principle protein-dye bind- <br /> whether Cdc3 lp-binding site(s) Karlp fulfill essen-                       ing. Anal. Biochem. 72:248-254. <br />                                                                                   Byers, B. 1981a. Cytology yeast life cycle. In The Molecular Biology <br /> tial function?                                                                       Yeast Saccharomyces-Life Cycle Inheritance. Stratbern, J. N., <br />    Vallen et al. (1994) proposed model Karlp helps                        E. W. Jones, J. R. Broach, editors. Cold Spring Harbor Laboratory, <br /> to localize Cdc31p SPB Cdc31p initiates                          Cold Spring Harbor, 59-96. <br />                                                                                   Byers, B. 1981b. Multiple roles spindle pole bodies life cycle of <br /> SPB duplication interaction downstream effector.                          Saccharomyces cerevisiae. In Mol. Gen. Yeast. Wettstein, D. yon, A. <br /> We favor modified version model Cdc31p                            Stenderup, M. Kielland-Brandt, J. Friis, editors, Alfred Benzon Symp., <br /> and Karlp permanent components cytoplasmic                           Munksgaard, Copenhagen. 16:119-133. <br />                                                                                   Byers, B., L. Goetsch. 1975. Behavior spindles spindle plaques in <br /> of half bridge SPB (Spang et al., 1993; Figs. 2                       cell cycle conjugation Saccharomyces cerevisiae. J. Bacteriol. <br /> 3). Cdc31p Karlp form complex                             124:511-523. <br />                                                                                   Conde, J., G. R. Fink. 1976. A mutant ofSaccharomyces cerevisiae defec- <br /> additional protein Xp (Fig. 9 B). Xp binding sites                           tive nuclear fusion. Proc. Natl. Acad. Sci. USA. 73:3651-3655. <br /> both Karlp Cdc3 lp. A potential candidate Xp 30-                     Dower, W. J., J. F. Miller, C. W. Ragsdale. 1988. High efficiency trans- <br /> kD protein demonstrated cross-linking                              formation E. coil high voltage electroporation. Nucleic Acids Res. <br />                                                                                       16:127-145. <br /> studies to Cdc31p (A. Spang, unpublished obser-                        Geiser, J. R., H. A. Sundberg, B. H. Chang, E. G. D. Muller, T. N. Davis. <br /> vations). Signals Cdc31p Karlp trans-                               1993. The essential mitotic target calmodulin 110-kilodalton compo- <br /> mitted Xp, initiates formation satellite                        nent spindle pole body Saccharomyces cerevisiae. Mol. Cell. Biol. <br />                                                                                      13:7913-7924. <br /> in early Gz phase cell cycle. The Karlp signal                       Glenney, J. R., K. Weber. 1980. Calmodulin-binding proteins the <br /> be dephosphorylation Karlp end mitosis.                             microffiamentspresent isolated brush borders microvillus intestinal <br />                                                                                      epithelial ceils. J. Biol. Chem. 255:10551 - 10554. <br /> Cdc31p, hand, sense local changes                           Guthrie, C., G. R. Fink. 1991. Guide Yeast Genetics Molecular Biol- <br /> Ca2&#195;&#183; concentration. We assume signals transmitted                           ogy. Methods Enzymol. 194:12-15. <br /> to Xp Karlp Cdc31p way redundant.                              Harlow, E., D. Lane. 1988. Antibodies - A Laboratory Manual, Cold <br />                                                                                      Spring Harbor Laboratory, Cold Spring Harbor. 285-318. <br /> However, possible Karlp Cdc3 lp active                      Jansen, R., D. Tollervey, E. C. Hurt. 1993. A U3 snoRNP protein with <br /> during different phases cell cycle. Mutations                              homology splicing factor PRP4 G/$ domains required ribosomal <br /> CDC31 result Cdc3 lp* activated earlier                          RNA processing. EMBO (Fur. Mol. Biol. Organ.) J. 12:2549-2558. <br />                                                                                   Kilmartin, J. V., S. L. Dyos, D. Kershaw, J. T. Finch. 1993. A spacer <br /> in cell cycle, altered binding constant                        protein Saccharomyces cerevisiae spindle pole body transcrip- <br /> Ca2&#195;&#183;, fully overlaps Karlp signal.                            tion cell cycle-regulated. J. Cell BioL 123:1175-1184. <br />                                                                                   Laemmli, U. K. 1970. Cleavage structural proteins assembly of <br /> This explain certain mutations CDC31                                head bacteriophage T4. Nature (Lond.). 227:680-685. <br /> substitute deletions KARL In summary, consider                          Lukas, T. J., W. H. Burgess, F. G. Prendergast, W. Lau, D. M. Watterson. <br /> the Cdc31p/Karlp/Xp complex key regulator SPB                              1986. Calmodulin binding domains: Characterization phosphorylation <br />                                                                                      calmodulin binding site myosin light chain kinase. Biochemistry. <br /> duplication transmit cell cycle-specific signals                        25:1458-1464. <br /> yet unknown components SPB.                                                Mirzayan, C., C. S. Copeland, M. Snyder. 1992. The NUF1 gene encodes <br />                                                                                      essential coiled-coil related protein potential component the <br />                                                                                      yeast nucleoskeleton. J. Cell Biol. 116:1319-1332. <br /> We thank S. Steyrer excellent technical assistance, Dr. H.-G. Heidrich        Moreno, S., P. Nurse. 1990. Substrates p34Cd&#194;&#162;2:in vivo veritas? Cell. <br /> (Max-Planck Institute Biochemistry, Martinsried, Germany) helpful            61:549-551. <br /> discussions U. Fackler construction strain UFM2. Dr. J. Kil-       Mountain, H. A., A. S. Bystrtm, J. T. Larsen, C. H. Korch, 1991. Four <br /> martin (Medical Research Council, Cambridge, England) gratefully ac-              major transcriptional responses methionine/threonine biosynthetic <br />                                                                                      pathway Saccharomyces cerevisiae. Yeast. 7:781-803. <br /> knowledged generous gift mouse mAbs 90-kD SPB              O&apos;Neil, K. T., H. R. Wolfe, Jr., S. Erickson-Viitanen, W. F. DeGrado. 1987. <br /> protein. We thank Dr. E. Hurt (EMBL, Heidelberg, Germany) anti-              Fluorescence properties calmodulin-binding peptides reflect alpha-helical <br /> NOPI/2 antibodies. Yeast strains S288C, Y255, Y49 MS2083                    periodicity. Science (Wash. DC). 236:1454-1456. <br /> generous gifts Drs. R. Mortimer (University California, Berkeley,         Preuss, D., J. Mulholland, C. A. Kaiser, P. Orlean, C. Albright, M. D. Rose, <br />                                                                                      P. W. Robbins, D. Botstein. 1991. Structure yeast endoplasmic <br /> CA), T. Schuster (University W/irzburg, Germany), K. Nasmyth                      reticulum: Localization ER proteins using immunofluorescence im- <br /> (I.M.P., Vienna, Austria), M. Rose (Princeton University, NJ), respec-           munoelectron microscopy. Yeast. 7:891-911. <br /> tively. Plasmids GTEP-I p M M 6 obtained Drs. B. Futcher            Reimann, E. M., K. Titani, L. H. Ericson, R. D. Wade, E. H. Fischer and <br /> (Cold Spring Harbor, NY) G. Fink (Whitehead Institute, MIT, MA).                 K. A. Walsh. 1984. Homology &quot;r subunit phosphorylase b kinase <br />                                                                                      cAMP-dependent protein kinase. Biochemistry. 23:4185--4192. <br />    This work supported grant Bundesministerium fOr For-           Rose, M. D., G. R. Fink. 1987. KARl, gene required function both <br /> schung und Technologie.                                                              intranuclear extranuclear microtubules yeast. Cell. 48:1047-1060. <br />                 <br /> </body></html>